Journal
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
Volume 118, Issue 3, Pages 320-329Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.oooo.2014.05.004
Keywords
-
Categories
Funding
- Foundation for Continuing Education and Research of the Canadian Association of Oral and Maxillofacial Surgeons
- Lloyd Carr-Harris Foundation
Ask authors/readers for more resources
Objective. Osteopontin (OPN) plays a role in tumor progression. This study aimed to determine the expression of OPN, CD44, and integrin alpha(v)beta(3) in pleomorphic adenoma (PA), acinic cell adenocarcinoma (ACA), and mucoepidermoid carcinoma (MEC). Study Design. Immunohistochemistry was used to semiquantify the levels of expression of OPN and its receptors in normal salivary glands (NSG) (n = 20), PA (n = 20), ACA (n = 11), and MEC (n = 29). Results. OPN expression was increased in ACA and MEC compared with PA and NSG (median sCores, 6, 6, 4, and 4, respectively). CD44 expression was increased in ACA and reduced in MEC and PA compared with NSG (median scores, 8, 4, 3, and 5, respectively). Integrin alpha(v)beta(3) median scores were 5 in ACA, 1 in MEC, and 0 in PA and NSG. Conclusions. OPN is expressed in salivary gland tumors and is at higher levels in ACA and MEC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available